Pharmaceutical During a meeting last week at the European Medicines Agency, the EMA’s executive director, Guido Rasi, and the national manager of the Australian Therapeutics Goods Administration (TTG) John Skerritt, announced today that the two regulators have agreed to share the full assessment reports related to marketing authorizations of orphan medicines, which are intended to treat rare diseases. 7 April 2014